Clinical Trials Browser

Phase 2 × Liver Neoplasms × cixutumumab × Clear all

NCT00906373 2018-06-04

A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver

Phase 2 Completed

47 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms